Indo Amines AGM approves FY26 results, 10% dividend, and director re-appointments
- Shareholders approved FY26 financial statements and a 10% final dividend of ₹0.50 per share
- Directors Saji Jose and Tejaswini Dalvi were re-appointed; Rahul Chitnis appointed as Independent Director
- Promoter group voted in favor of all resolutions with 91.79% participation rate
- Dividend resolution faced 1.86% total opposition, primarily from public non-institutional holders

*this image is generated using AI for illustrative purposes only.
Indo Amines shareholders approved the adoption of standalone and consolidated audited financial statements for FY26, along with a 10% final dividend (₹0.50 per equity share), during the company’s 33rd Annual General Meeting (AGM) held on September 24, 2026.
The meeting, conducted via video conferencing, also ratified the re-appointment of directors Saji Jose and Tejaswini Dalvi, the appointment of Rahul Chitnis as Independent Director, and the remuneration of the Cost Auditor for FY27. All resolutions were passed with requisite majority as per the scrutinizer’s report.
Financial Performance Overview
During the meeting, Chairman Pradeep Thakur highlighted the company’s resilience amid global raw material volatility and supply chain disruptions. The financial results reflect growth across both top and bottom lines.
| Metric | FY26 | FY25 | Change |
|---|---|---|---|
| Consolidated Revenue | ₹1,159.66 crore | ₹1,078.68 crore | +7.5% |
| Profit Before Tax | ₹106.11 crore | ₹76.95 crore | +37.9% |
| Profit After Tax | ₹79.33 crore | ₹55.90 crore | +41.9% |
On a standalone basis, Indo Amines reported revenue growth of 5.81%, with an EBITDA margin of 13.13% and a PAT margin of 7.05%.
What the Numbers Show
The disparity between revenue growth (7.5%) and Profit After Tax growth (41.9%) indicates significant operating leverage or margin expansion during FY26. While top-line growth was moderate, the bottom-line expansion suggests improved cost efficiency or better realization rates, as evidenced by the standalone EBITDA margin holding at 13.13%.
Strategic Developments and Governance
Managing Director Vijay Palkar noted the launch of "Morpholine and Derivatives" at the Dhule plant, expanding the product portfolio for domestic and international markets. The company plans to pursue strategic acquisitions and backward integration to diversify into value-added chemistries.
Key governance updates from the AGM include:
- Re-appointment of Saji Jose and Tejaswini Dalvi as directors retiring by rotation.
- Appointment of Rahul Chitnis as Independent Director for a one-year term.
- Ratification of remuneration for the Cost Auditor for FY27.
Voting Results Summary
The scrutinizer’s report detailed the voting outcomes for all six resolutions. Promoter and Promoter Group held 4,24,04,506 shares, with 3,89,23,096 votes polled (91.79% of their holding). Public non-institutional holders polled approximately 95.98 lakh votes out of their 3,01,66,226 shares held.
| Resolution | Total Votes Polled | % In Favour | % Against |
|---|---|---|---|
| Adoption of Financial Statements | 4,85,22,139 | 99.9978% | 0.0022% |
| Declaration of Final Dividend | 4,85,21,739 | 98.1429% | 1.8571% |
| Re-appointment of Saji Jose | 4,85,21,739 | 99.9967% | 0.0033% |
| Re-appointment of Tejaswini Dalvi | 4,85,21,739 | 99.9959% | 0.0041% |
| Ratification of Cost Auditor Remuneration | 4,85,21,739 | 99.9970% | 0.0030% |
| Appointment of Rahul Chitnis | 4,85,21,739 | 99.9960% | 0.0040% |
The dividend resolution saw the highest dissent from public shareholders, with 9,01,093 votes against, representing 9.39% of the public non-institutional votes polled on that item. No invalid votes were recorded for any resolution.
Historical Stock Returns for Indo Amines
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -6.37% | -14.60% | +9.46% | +19.75% | -0.33% | +18.84% |
How will the newly launched Morpholine and Derivatives capacity at the Dhule plant impact Indo Amines' revenue mix and margin profile in FY27?
What specific value-added chemistry segments is Indo Amines targeting for its planned backward integration and strategic acquisitions?
Can the company sustain the significant operating leverage seen in FY26 if global raw material volatility persists in FY27?


































